vTv Therapeutics
VTVT
#9430
Rank
โ‚น11.68 B
Marketcap
โ‚น2,967
Share price
-2.94%
Change (1 day)
120.86%
Change (1 year)

Revenue for vTv Therapeutics (VTVT)

Revenue in 2026 (TTM): โ‚น3.44 Billion

According to vTv Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น3.55 Billion. In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of โ‚น87.24 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for vTv Therapeutics from 2014 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น3.44 B
2025 N/A-100%
2024 โ‚น87.24 M
2023 N/A-100%
2022 โ‚น0.16 B-43.98%
2021 โ‚น0.29 B-36.45%
2020 โ‚น0.46 B137.99%
2019 โ‚น0.19 B-77.33%
2018 โ‚น0.86 B4579.17%
2017 โ‚น18.58 M-56.87%
2016 โ‚น43.08 M24.91%
2015 โ‚น34.49 M-64.87%
2014 โ‚น98.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น56.11 B 1,477.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.82 M-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA